These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18365932)

  • 41. HIV prevention for injecting drug users: the first 25 years and counting.
    Des Jarlais DC; Semaan S
    Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reliability of interview responses of injecting drug users.
    Ross MW; Stowe A; Wodak A; Gold J
    J Addict Dis; 1995; 14(2):1-12. PubMed ID: 8541354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
    Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disease-related stigma: comparing predictors of AIDS and cancer stigma.
    Greene K; Banerjee SC
    J Homosex; 2006; 50(4):185-209. PubMed ID: 16723345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attitudes towards HIV/AIDS among four year medical students at the University of Zagreb Medical School--better in 2002 than in 1993 but still unfavorable.
    Tesić V; Kolarić B; Begovac J
    Coll Antropol; 2006 Dec; 30 Suppl 2():89-97. PubMed ID: 17508481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emotional stress, psychosocial variables and coping associated with hepatitis C virus and human immunodeficiency virus infections in intravenous drug users.
    Grassi L; Satriano J; Serra A; Biancosino B; Zotos S; Sighinolfi L; Ghinelli F
    Psychother Psychosom; 2002; 71(6):342-9. PubMed ID: 12411769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modelling and calibration of the hepatitis C epidemic in Australia.
    Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
    Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
    Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
    Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
    Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
    Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
    Crofts N; Aitken CK; Kaldor JM
    Med J Aust; 1999 Mar; 170(5):220-1. PubMed ID: 10092920
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatitis C prevention and true harm reduction.
    Madden A; Cavalieri W
    Int J Drug Policy; 2007 Oct; 18(5):335-7. PubMed ID: 17854719
    [No Abstract]   [Full Text] [Related]  

  • 52. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
    Ellard J
    Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medical students' attitudes toward AIDS, homosexual, and intravenous drug-abusing patients: a re-evaluation in New York City.
    McGrory BJ; McDowell DM; Muskin PR
    Psychosomatics; 1990; 31(4):426-33. PubMed ID: 2247572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measuring attitudes toward persons with AIDS: the AAS-G as an alternate form of the AAS.
    Froman RD; Owen SV
    Sch Inq Nurs Pract; 2001; 15(2):161-74; discussion 175-7. PubMed ID: 11695492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs.
    Shannon K; Rusch M; Morgan R; Oleson M; Kerr T; Tyndall MW
    Subst Use Misuse; 2008; 43(3-4):521-34. PubMed ID: 18365948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presence of hepatitis C virus in syringes confiscated in prisons in Australia.
    Dolan K; Larney S; Jacka B; Rawlinson W
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1655-7. PubMed ID: 19788605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Risk factors for hepatitis C among injecting drug users in Oslo].
    Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The changing epidemiology of prevalent diagnosed HIV infections in Taiwan, 1984-2005.
    Yang CH; Yang SY; Shen MH; Kuo HS
    Int J Drug Policy; 2008 Aug; 19(4):317-23. PubMed ID: 18638704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attitudes of advanced dental education students toward individuals with AIDS.
    Cohen LA; Romberg E; Grace EG; Barnes DM
    J Dent Educ; 2005 Aug; 69(8):896-900. PubMed ID: 16081572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Universal access to HIV/AIDS treatment for injecting drug users: keeping the promise.
    Ball AL
    Int J Drug Policy; 2007 Aug; 18(4):241-5. PubMed ID: 17689371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.